Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ

(ORNBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Orion Oyj : Finnish drugmaker Orion's third-quarter profit and sales fall

10/21/2020 | 05:26am EST

HELSINKI (Reuters) - Finnish drugmaker Orion on Wednesday reported a drop in quarterly profit and sales, after raising its full-year outlook a day earlier, helped by higher sales of its sedative Dexdor in March and April.

Orion's operating profit in the quarter fell 28% from a year earlier to 65.1 million euros ($77.1 million) on sales down nearly 12% to 250.3 million euros.

On Tuesday, Orion said it expects its 2020 operating profit to be higher or clearly higher than in 2019, compared to a June forecast of slightly higher or higher.

($1 = 0.8440 euros)

(Reporting by Anne Kauranen, editing by Louise Heavens)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ORION HOLDINGS CORP. 0.00% 13150 End-of-day quote.-0.38%
ORION OYJ 2.54% 39.15 Delayed Quote.4.32%
All news about ORION OYJ
01/12ORION OYJ : Recommendation by the Nomination Committee concerning the Board of D..
AQ
2020NUVO PHARMACEUTICALS INC : . - Miravo Healthcare Ireland Enters into Suvexx Lice..
AQ
2020ORION OYJ : 8,242 Orion Corporation A shares converted into B shares
AQ
2020ORION OYJ : invests EUR 17 million in its production plants in Turku
PU
2020ORION OYJ : Prosecutor pressed charges against a member of Orion's Board of Dire..
PU
2020ORION OYJ : Prosecutor pressed charges against a member of Orion's Board of Dire..
AQ
2020Prosecutor pressed charges against a member of Orion's Board of Directors for..
GL
2020ORION OYJ : Composition of the Nomination Committee of Orion Corporation
PU
2020ORION OYJ : Composition of the Nomination Committee of Orion Corporation
AQ
2020Composition of the Nomination Committee of Orion Corporation
GL
More news
Financials
Sales 2020 1 090 M 1 316 M 1 316 M
Net income 2020 236 M 284 M 284 M
Net cash 2020 134 M 162 M 162 M
P/E ratio 2020 23,4x
Yield 2020 3,79%
Capitalization 5 497 M 6 647 M 6 638 M
EV / Sales 2020 4,92x
EV / Sales 2021 5,03x
Nbr of Employees 3 320
Free-Float 86,5%
Chart ORION OYJ
Duration : Period :
Orion Oyj Technical Analysis Chart | ORNBV | FI0009014377 | MarketScreener
Technical analysis trends ORION OYJ
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 32,95 €
Last Close Price 39,15 €
Spread / Highest target 7,28%
Spread / Average Target -15,8%
Spread / Lowest Target -28,5%
EPS Revisions
Managers and Directors
NameTitle
Timo Antero Lappalainen President & Chief Executive Officer
Satu Maarit Ahomäki Senior Vice President-Commercial Operations
Jari Ilmari Karlson Chief Financial Officer & SVP-Animal Health
Sinikka Markkula Chief Information Officer
Minna Ruotsalainen Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ORION OYJ4.32%6 647
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993